Why BioCryst Pharmaceuticals Stock Is Jumping Today
Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) were 8.1% higher as of 12:18 p.m. EDT on Monday after rising as much as 10.5% earlier in the day. The gain reflects continued momentum following BioCryst's announcement last week of U.K. approval of Orladeyo in preventing recurrent hereditary angioedema (HAE) attacks.
Today's nice gain for the biotech stock probably has less to do with the U.K. approval itself. It's likely more reflective of investors' overall optimism about Orladeyo's prospects.
Image source: Getty Images.
Source Fool.com
